Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety Study (TRIMS A)

This study has been completed.
University of Copenhagen
Statens Serum Institut
Copenhagen University Hospital, Hvidovre
OvaMed GmbH
Information provided by (Responsible Party):
Ana Voldsgaard, Rigshospitalet, Denmark Identifier:
First received: October 7, 2009
Last updated: November 9, 2011
Last verified: November 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2011
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):